Trial Profile

A Phase II/III trial with IV Ampion in patients with COVID-19

Status: Recruiting

Phase of Trial: Phase II/III

Latest Information Update: 06 Jan 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs DMI 9523 (Primary)
Indications COVID 2019 infections
Focus Therapeutic Use
Sponsors Ampio Pharmaceuticals

Most Recent Events

04 Jan 2021 According to an Ampio Pharmaceuticals media release, Status changed from planning to recruiting.
17 Dec 2020 According to an Ampio Pharmaceuticals media release, clinical sites in Israel will be used concurrently with sites in the United States, as Israel has been recognized by the FDA to support the safety and efficacy of drugs in the United States.
11 Sep 2020 New trial record

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com